Key Facts GPs Should Know About GLP-1 Analogs
Family Medicine Initiative
APRIL 9, 2024
13 Here is some evidence: From 2004-2020, 8,718 GLP-1 analogs-associated tumors were reported to the FDA. Both the FDA and EMA recommend that doctors monitor patients with diabetic retinopathy who are undergoing semaglutide treatment closely. mg is not recommended. 9 The American Academy of Ophthalmology offers more information here 11.
Let's personalize your content